Stewart J Tepper

Summary

Publications

  1. ncbi request reprint Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine
    Stewart J Tepper
    Cleveland Clinic, Center for Headache and Pain, Department of Neurology, Neurological Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Opin Investig Drugs 10:711-20. 2009
  2. ncbi request reprint Safety and rational use of the triptans
    S J Tepper
    New England Center for Headache, Stamford, Connecticut, USA
    Med Clin North Am 85:959-70. 2001
  3. ncbi request reprint Complementary and alternative treatments for childhood headaches
    Stewart J Tepper
    Center for Headache and Pain, T33, Neurological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Pain Headache Rep 12:379-83. 2008
  4. doi request reprint An overview of migraine pathophysiology
    Stewart J Tepper
    The New England Center for Headache, Stamford, CT 06902, USA
    Postgrad Med 114:5-10. 2003
  5. ncbi request reprint The patent foramen ovale-migraine question
    S J Tepper
    The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902, USA
    Neurol Sci 28:S118-23. 2007
  6. ncbi request reprint Perimenstrual migraines: are they different from migraines in general?
    Stewart J Tepper
    Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Curr Pain Headache Rep 12:463-7. 2008
  7. ncbi request reprint Safety profile of the triptans
    Stewart J Tepper
    The New England Center for Headache, 778 Long Ridge Rd, Stamford, CT 06902, USA
    Expert Opin Drug Saf 2:123-32. 2003
  8. ncbi request reprint Mechanisms of action of the 5-HT1B/1D receptor agonists
    Stewart J Tepper
    New England Center for Headache, 778 Long Ridge Rd, Stamford, CT 06902 1251, USA
    Arch Neurol 59:1084-8. 2002
  9. ncbi request reprint Ethical considerations in cluster headache research
    Stewart J Tepper
    The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902, USA
    Curr Pain Headache Rep 6:47-51. 2002
  10. ncbi request reprint Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases
    Alan M Rapoport
    Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Headache 43:482-9. 2003

Detail Information

Publications63

  1. ncbi request reprint Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine
    Stewart J Tepper
    Cleveland Clinic, Center for Headache and Pain, Department of Neurology, Neurological Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Opin Investig Drugs 10:711-20. 2009
    ..It was concluded that, if these hepatic toxicities are not observed in ongoing/future trials of the acute use of telcagepant, then this agent may offer an alternative to triptan therapy for the treatment of migraine...
  2. ncbi request reprint Safety and rational use of the triptans
    S J Tepper
    New England Center for Headache, Stamford, Connecticut, USA
    Med Clin North Am 85:959-70. 2001
    ..This approach increases the likelihood of achieving a pain-free response, with fewer adverse events and lower likelihood of the headache recurring...
  3. ncbi request reprint Complementary and alternative treatments for childhood headaches
    Stewart J Tepper
    Center for Headache and Pain, T33, Neurological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Pain Headache Rep 12:379-83. 2008
    ..There is one positive uncontrolled trial each for coenzyme Q10 and Petasites for prevention of pediatric migraine. There are no trials to indicate the safety or efficacy of riboflavin or feverfew for pediatric headache...
  4. doi request reprint An overview of migraine pathophysiology
    Stewart J Tepper
    The New England Center for Headache, Stamford, CT 06902, USA
    Postgrad Med 114:5-10. 2003
    ..Better understanding of the physiologic and molecular events in migraine may lead to even better targets for therapy...
  5. ncbi request reprint The patent foramen ovale-migraine question
    S J Tepper
    The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902, USA
    Neurol Sci 28:S118-23. 2007
    ..One reported secondary endpoint showed a significant 42% reduction of migraine days, suggesting the need for further randomised, sham-controlled PFO closure studies...
  6. ncbi request reprint Perimenstrual migraines: are they different from migraines in general?
    Stewart J Tepper
    Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Curr Pain Headache Rep 12:463-7. 2008
    ..Clinicians must have compassion and skill to manage patients with MRM...
  7. ncbi request reprint Safety profile of the triptans
    Stewart J Tepper
    The New England Center for Headache, 778 Long Ridge Rd, Stamford, CT 06902, USA
    Expert Opin Drug Saf 2:123-32. 2003
    ..Serotonin syndrome has been a concern, but one large prospective study failed to document a single case, and reports are sporadic and not clearly causative...
  8. ncbi request reprint Mechanisms of action of the 5-HT1B/1D receptor agonists
    Stewart J Tepper
    New England Center for Headache, 778 Long Ridge Rd, Stamford, CT 06902 1251, USA
    Arch Neurol 59:1084-8. 2002
    ....
  9. ncbi request reprint Ethical considerations in cluster headache research
    Stewart J Tepper
    The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902, USA
    Curr Pain Headache Rep 6:47-51. 2002
    ..There is justification for studying attacks untreated, and even for precipitating these attacks. Placebo-controlled studies should only be undertaken for regulatory purposes; otherwise, active control should be used...
  10. ncbi request reprint Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases
    Alan M Rapoport
    Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Headache 43:482-9. 2003
    ..To review the efficacy of naratriptan as preventive treatment in 27 patients with chronic migraine refractory to other commonly used preventive therapies...
  11. doi request reprint Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia
    Stewart J Tepper
    Neurological Institute, Cleveland Clinic Center for Headache and Pain, Cleveland, OH 44195 0002, USA
    Headache 52:37-47. 2012
    ..The efficacy of triptans for migraine resolution has been shown to be markedly reduced when administered in patients with established cutaneous allodynia...
  12. ncbi request reprint Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study
    Fred D Sheftell
    The New England Center for Headache, College of Medicine, Stanford, CT, USA
    Headache 45:1400-6. 2005
    ..To assess the efficacy, safety, and tolerability of daily naratriptan in the preventive treatment of transformed migraine (TM) refractory to previous first line therapies...
  13. ncbi request reprint Sumatriptan: a decade of use and experience in the treatment of migraine
    Fred D Sheftell
    The New England Center for Headache, PC 778 Long Ridge Road, Stamford, CT 06902 1251, USA
    Expert Rev Neurother 4:199-209. 2004
    ..It is useful for the full range of attacks experienced by a migraine suffer. The aim of this review is to provide an overview of the first 10 years of the use of sumatriptan...
  14. doi request reprint Sumatriptan/naproxen sodium combination for the treatment of migraine
    Catalina Cleves
    Department of Pediatric Neurology, Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, 778 Long Ridge Rd, Stamford, CT 06902, USA
    Expert Rev Neurother 8:1289-97. 2008
    ..The clinical advantage of the sumatriptan and naproxen sodium combination is likely to be prolonged benefit per attack, that is, a sustained pain-free response...
  15. doi request reprint Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics: the menstrual migraine assessment tool
    Stewart J Tepper
    Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Headache 48:1419-25. 2008
    ..To develop and validate a brief questionnaire to screen for menstrual migraine (MM), and to estimate MM prevalence in an obstetrics and gynecology (OB/GYN) setting in a pilot study...
  16. doi request reprint The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper
    Randolph W Evans
    Department of Neurology, Baylor College of Medicine, Houston, TX, USA
    Headache 50:1089-99. 2010
    ..This American Headache Society Position Paper further reviews the available evidence of the potential risk of combining triptans with other serotonergic agents...
  17. ncbi request reprint Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases
    Stewart J Tepper
    The New England Center for Headache, Stamford, CT 06902, USA
    Headache 44:794-800. 2004
    ..To review the efficacy of botulinum neurotoxin type A (BoNT-A) in the preventive treatment of refractory headache...
  18. ncbi request reprint The triptan formulations : how to match patients and products
    Alan M Rapoport
    Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    CNS Drugs 17:431-47. 2003
    ..Use of the methods outlined in this review in choosing a triptan for an individual patient is probably more likely to lead to migraine relief than making an educated guess as to which triptan is most appropriate...
  19. ncbi request reprint Burden of migraine in Brazil: estimate of cost of migraine to the public health system and an analytical study of the cost-effectiveness of a stratified model of care
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Headache 43:742-54. 2003
    ..The search for rationality in health expenses in developing countries collides with the lack of effectively conducted epidemiologic studies...
  20. doi request reprint Headache following intracranial neuroendovascular procedures
    Eric P Baron
    Cleveland Clinic Neurological Institute Neurology, Center for Headache and Pain, Center for Regional Neurology, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Headache 52:739-48. 2012
    ....
  21. doi request reprint Adverse effects of medications commonly used in the treatment of migraine
    Chad A Whyte
    Center for Headache and Pain, Cleveland Clinic Foundation, 9500 Euclid Ave T33, Cleveland OH 44195, USA
    Expert Rev Neurother 9:1379-91. 2009
    ..This article reviews adverse events associated with migraine and medications, and their implications in clinical treatment...
  22. ncbi request reprint Tinnitus in migraine: an allodynic symptom secondary to abnormal cortical functioning?
    Michel Volcy
    The New England Center for Headache, Stanford, Connecticut 06902, USA
    Headache 45:1083-7. 2005
    ..We hypothesize that the tinnitus intensity increase could be an allodynic symptom related to CS, or alternatively could be associated with cortical hyperexcitability...
  23. ncbi request reprint New migraine preventive options: an update with pathophysiological considerations
    Marcelo E Bigal
    New England Center for Headache, Stamfor, CT, USA
    Rev Hosp Clin Fac Med Sao Paulo 57:293-8. 2002
    ..The better knowledge about migraine pathophisiology led us to discuss new treatment options...
  24. doi request reprint Unusual headaches in the elderly
    Cynthia C Bamford
    Center for Headache and Pain, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Curr Pain Headache Rep 15:295-301. 2011
    ..This review provides an overview of some of the major and unusual geriatric headaches, both primary and secondary...
  25. doi request reprint Role of greater occipital nerve blocks and trigger point injections for patients with dizziness and headache
    Eric P Baron
    Department of Neurology, Cleveland Clinic Neurological Institute, Center for Headache and Pain, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Neurologist 17:312-7. 2011
    ..Cervicogenic headache frequently coexists with complaints of dizziness, tinnitus, nausea, imbalance, hearing complaints, and ear/eye pain. Controversy exists as to whether this constellation of symptoms may be cervically mediated...
  26. doi request reprint Dihydroergotamine and its use in migraine with posterior fossa symptoms
    Chad A Whyte
    Center for Headache and Pain, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Headache 50:1419-23. 2010
    ..Dihydroergotamine (DHE) has been used for decades to treat migraine, but is currently contraindicated in patients with hemiplegic migraine and basilar-type migraine (BTM)...
  27. doi request reprint Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine
    Stewart J Tepper
    Center for Headache and Pain, Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Headache 48:1259-68. 2008
    ..The potential for a migraine-specific medication without vasoconstrictive or vascular side effects is enormous. CGRP receptor blockade may also have applications in other pathologic and pain syndromes...
  28. ncbi request reprint Headache attributed to hypothyroidism
    Deborah E Tepper
    Albert Einstein College of Medicine, Department of Neurology, Bronx, NY 10451, USA
    Curr Pain Headache Rep 11:304-9. 2007
    ..We also review the prevalence, etiology, and principles of treatment of hypothyroidism. Because hypothyroidism is a treatable cause of secondary headaches, doctors should be aware of this relationship...
  29. ncbi request reprint The serotonin syndrome, triptans, and the potential for drug-drug interactions
    Robert E Shapiro
    Department of Neurology, College of Medicine, University of Vermont, Burlington, VT, USA
    Headache 47:266-9. 2007
    ..We conclude that it is currently unclear whether administration of triptans with other serotonergic medications increases the risk of serotonin syndrome...
  30. ncbi request reprint Treatment of menstrual migraine: evidence-based review
    Stewart J Tepper
    New England Center for Headache, Yale University School of Medicine, New Haven, Conn, USA
    Manag Care 16:10-4; discussion 15-7. 2007
  31. ncbi request reprint Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study
    Stewart J Tepper
    New England Center ofr Headache, Stamford, CT 06902, USA
    Headache 46:115-24. 2006
    ..To evaluate the efficacy and tolerability of sumatriptan tablets in adults who meet International Headache Society (IHS) criteria for probable migraine but who do not meet IHS criteria for migraine with or without aura...
  32. doi request reprint Breaking the cycle of medication overuse headache
    Stewart J Tepper
    Center for Headache and Pain, Neurological Institute, T33, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 77:236-42. 2010
    ..Breaking the cycle involves weaning the patient from the overused medications, setting up a preventive regimen, and setting strict limits on the use of medications to relieve acute symptoms...
  33. ncbi request reprint Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Office 334 A, Rousso Building, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Headache 43:336-42. 2003
    ..Chronic migraine is the most common type of chronic daily headache seen in headache tertiary care centers. Most patients with chronic migraine report their ability to function and feeling of well-being as severely impaired...
  34. doi request reprint Revisiting the role of ergots in the treatment of migraine and headache
    Eric P Baron
    Headache Center, Cleveland Clinic, Cleveland, OH 44195, USA
    Headache 50:1353-61. 2010
    ..Redefining where in the headache treatment spectrum ergots belong and deciding when they may be the optimal choice of treatment is necessary...
  35. doi request reprint QT prolongation, Torsade de Pointes, myocardial ischemia from coronary vasospasm, and headache medications. Part 2: review of headache medications, drug-drug interactions, QTc prolongation, and other arrhythmias
    Mark J Stillman
    Headache Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Headache 53:217-24. 2013
    ..This may be the place to start in protecting patients from these cardiac adverse events...
  36. doi request reprint Medication-overuse headache
    Stewart J Tepper
    Cleveland Clinic, Headache Center, Cleveland, OH, USA
    Continuum (Minneap Minn) 18:807-22. 2012
    ..This review will describe (1) MOH clinical features and diagnosis, (2) pathophysiology and structural and functional MOH brain changes, and (3) prevention and treatment of MOH...
  37. doi request reprint Neurostimulation for primary headache disorders: Part 2, review of central neurostimulators for primary headache, overall therapeutic efficacy, safety, cost, patient selection, and future research in headache neuromodulation
    Brian Jenkins
    Neurological Center for Headache and Pain, Cleveland Clinic, Cleveland, OH 44195, USA
    Headache 51:1408-18. 2011
    ..Part 2 also analyzes overall therapeutic efficacy, safety, cost, patient selection, and recommendations for further research of neurostimulation modalities based on available data...
  38. doi request reprint Iron deposition in pain-regulatory nuclei in episodic migraine and chronic daily headache by MRI
    Stewart J Tepper
    Cleveland Clinic Headache Center, Cleveland, OH 44195, USA
    Headache 52:236-43. 2012
    ..Magnetic resonance imaging (MRI) findings of iron accumulation in the brain, especially in periaqueductal gray and red nucleus, have been correlated with both duration of illness and frequency of attacks...
  39. pmc MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments
    Stewart J Tepper
    Center for Headache and Pain, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195 0002, USA
    Mayo Clin Proc 86:948-55. 2011
    ..To evaluate the efficacy of MAP0004, an orally inhaled dihydroergotamine, for acute treatment of migraine when administered at various time points from within 1 hour to more than 8 hours after migraine onset...
  40. doi request reprint Acute treatment of migraine
    Stewart J Tepper
    Center for Headache and Pain, T33, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Neurol Clin 27:417-27. 2009
    ..Opioids and butalbital should be avoided in acute migraine treatment. Triptan type can be selected for patients by differences in speed or effect, formulation, and formulary tier...
  41. ncbi request reprint Ergotamine and dihydroergotamine: a review
    Marcelo E Bigal
    The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902, USA
    Curr Pain Headache Rep 7:55-62. 2003
    ..In patients with status migrainous and patients with frequent headache recurrence, ergotamine is still probably useful...
  42. doi request reprint Cluster headache: potential options for medically refractory patients (when all else fails)
    Stewart J Tepper
    Headache Center, Neurological Center for Pain, Cleveland Clinic, Cleveland, OH, USA
    Headache 53:1183-90. 2013
    ....
  43. doi request reprint Acute treatment of basilar-type migraine with greater occipital nerve blockade
    Eric P Baron
    Cleveland Clinic Neurological Institute Neurology, Center for Headache and Pain, Cleveland, OH, USA
    Headache 50:1057-9. 2010
    ..GON blockade may provide an additional option in acute management of BTM. It may be particularly useful when associated with prominent ipsilateral suboccipital tenderness...
  44. doi request reprint Acute treatment of migraines
    Arnaldo N Da Silva
    Center for Headache and Pain, Cleveland Clinic, Cleveland, OH 44195, USA
    CNS Drugs 26:823-39. 2012
    ..Narcotics and habituating medications should be avoided in the acute treatment of migraine, as the risk for transformation to chronic daily headache is excessively high at a relatively infrequent rate of exposure...
  45. pmc Ictal adiponectin levels in episodic migraineurs: a randomized pilot trial
    B Lee Peterlin
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Headache 53:474-90. 2013
    ..To assess ictal adiponectin (ADP) levels before and after acute abortive treatment in women episodic migraineurs...
  46. doi request reprint Advanced interventions for headache
    Stewart J Tepper
    Headache Center, Cleveland Clinic, Cleveland, OH 44195, USA
    Headache 52:50-4. 2012
    ..The most promise, with the best balance of efficacy vs adverse event prospects, may be occipital nerve stimulators or sphenopalatine ganglion stimulators...
  47. doi request reprint Neurostimulation for primary headache disorders, part 1: pathophysiology and anatomy, history of neuromodulation in headache treatment, and review of peripheral neuromodulation in primary headaches
    Brian Jenkins
    Neurological Center for Headache and Pain, Cleveland Clinic, Cleveland, OH 44195, USA
    Headache 51:1254-66. 2011
    ..Part 2 also contains an overall analysis of efficacy, safety, cost, patient selection, and suggestions for further study based on available evidence...
  48. ncbi request reprint Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
    Headache 42:862-71. 2002
    ..Dipyrone (Metamizol) has been used in the acute treatment of migraines in Brazil. Some investigators have found it to be a highly effective medication for migraine pain and associated symptoms...
  49. ncbi request reprint Patent foramen ovale and migraine: association, causation, and implications of clinical trials
    Stewart J Tepper
    Center for Headache and Pain, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Pain Headache Rep 13:221-6. 2009
    ..Difficulty with recruitment closed the MIST II and ESCAPE trials; the PREMIUM and PRIMA randomized controlled trials are ongoing at the time of this writing...
  50. ncbi request reprint Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study
    Stewart J Tepper
    The New England Center for Headache, Stamford, CT, USA
    Headache 44:856-64. 2004
    ..The premise upon which this approach is based-that is, that episodic, recurrent primary headache in the clinic is usually migraine-has not been evaluated in prospective clinical studies...
  51. doi request reprint Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation
    Stewart J Tepper
    Center for Headache and Pain, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave T33, Cleveland, OH 44195, USA
    Headache 49:983-9. 2009
    ..We report preliminary results of a novel acute treatment for intractable migraine. The sphenopalatine ganglion (SPG) has sensorimotor and autonomic components and is involved in migraine pathophysiology...
  52. ncbi request reprint 49th annual scientific meeting of the American Headache Society 2007
    Esther Rawner
    Yale University, School of Medicine, Department of Neurology, New Haven, CT 06520, USA
    Expert Rev Neurother 7:1093-5. 2007
  53. ncbi request reprint Hemicrania continua: a report of ten new cases
    Marcelo E Bigal
    International Headache Society Fellow, The New England Center for Headache, New York, NY, USA
    Arq Neuropsiquiatr 60:695-8. 2002
    ..Although the cardinal features of HC - continuous, unilateral, indomethacin responsive, remain strongly reliable, a refinement on the clinical characterization is needful and desired...
  54. ncbi request reprint New thoughts on sinus headache
    Stewart J Tepper
    New England Center for Headache, 778 Long Ridge Rd, Stamford, CT 06902, USA
    Allergy Asthma Proc 25:95-6. 2004
    ....
  55. ncbi request reprint Intranasal medications for the treatment of migraine and cluster headache
    Alan M Rapoport
    Columbia University College of Physicians and Surgeons, New York, NY, USA
    CNS Drugs 18:671-85. 2004
    ..Nevertheless, it is our opinion that nasal preparations increase therapeutic options and may result in faster response times and better efficacy than oral formulations and better patient satisfaction than injectable preparations...
  56. ncbi request reprint Zolmitriptan (Zomig)
    Alan M Rapoport
    College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Expert Rev Neurother 4:33-41. 2004
    ..5-mg dose at early time points. The physician can now choose the optimum route of delivery of zolmitriptan to stop the headache, increase the likelihood of reducing disability and restore the patient to complete functionality...
  57. ncbi request reprint Patterns of use of triptans and reasons for switching them in a tertiary care migraine population
    Fred D Sheftell
    Department of Psychiatry, New York Medical College, NY, USA
    Headache 44:661-8. 2004
    ..To assess the reasons for switching triptans within migraine patients presenting to a specialty clinic...
  58. ncbi request reprint Assessment of adverse events associated with triptans--methods of assessment influence the results
    Fred D Sheftell
    New York Medical College, Psychiatry, New York, NY, USA
    Headache 44:978-82. 2004
    ..However, the proportion of patients reporting side effects after any acute treatment may vary with regard to the method of assessment...
  59. pmc Patients' preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine
    Andrew J Dowson
    King s Headache Service, King s College Hospital, Denmark Hill, London SE5 9RS, UK
    J Headache Pain 6:112-20. 2005
    ..Patient preference is a sensitive clinical trial endpoint and physicians should consider using it when reviewing the efficacy of acute migraine medications...
  60. ncbi request reprint Role of melatonin in the pathophysiology of migraine: implications for treatment
    Barbara Vogler
    Jefferson Headache Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    CNS Drugs 20:343-50. 2006
    ..Future studies are necessary to further elucidate whether melatonin is a well tolerated, beneficial therapy, and to determine the optimal dose and formulation of melatonin for use in migraine therapy...
  61. ncbi request reprint Tailoring management strategies for the patient with menstrual migraine: focus on prevention and treatment
    Stewart J Tepper
    Yale University School of Medicine, New Haven, CT, USA
    Headache 46:S61-8. 2006
    ..The flexibility of using acute and preventive therapy allows physicians to tailor treatment of MM and meet the needs of individual patients...
  62. ncbi request reprint Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period
    Chelsea A Meskunas
    Princeton University, Molecular Biology, NJ, USA
    Headache 46:766-72. 2006
    ..To evaluate the substances associated with medication overuse headache (MOH) in a headache center, over the course of the past 15 years...
  63. ncbi request reprint Drug-induced serotonin syndrome: a review
    Christina Sun-Edelstein
    New York Headache Center, New York, NY, USA
    Expert Opin Drug Saf 7:587-96. 2008
    ..In this review, the pathophysiology, clinical features, implicated drugs, diagnosis and treatment of ST are discussed...